Powder: -20°C for 3 years | In solvent: -80°C for 1 year
FIN56 是一种铁死亡特异性诱导剂,能结合并激活角鲨烯合酶,可通过诱导 GPX4 降解来诱导铁死亡。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 237 | 现货 | ||
2 mg | ¥ 336 | 现货 | ||
5 mg | ¥ 527 | 现货 | ||
10 mg | ¥ 898 | 现货 | ||
25 mg | ¥ 1,680 | 现货 | ||
50 mg | ¥ 2,890 | 现货 | ||
100 mg | ¥ 5,190 | 现货 | ||
500 mg | ¥ 10,600 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 623 | 现货 |
产品描述 | FIN56 is a specific inducer of ferroptosis. |
体外活性 | FIN56 triggers ferroptosis through a mechanism involving the regulation of GPX4 protein abundance. FIN56 causes the loss of GPX4 activity in cell lysates. FIN56-induced cell death is suppressed by GFP-GPX4 fusion protein overexpression. |
体内活性 | NA |
细胞实验 | 1000 cells/36 μL are seeded in each well in 384-well plates. Lethal compounds are dissolved and a 2-fold, 12-point dilution series are prepared in DMSO. Compound solutions are further diluted with media at 1:25 and 4 μL/well of the diluted solutions are added to cell cultures immediately after cells are seeded. When ferroptosis inhibitors (100 μM α-tocopherol, 152 μM deferoxamine, or 10 μM U-0126) are co-treated with lethal inducers, they are supplemented to cell culture at the same time as lethal compounds are added, and the cells are incubated for 24 hrs. When other cell death modulating compounds (100 nM sodium selenite, 1 μM cerivastatin, 100 μg/mL mevalonic acid) are co-treated, they are first supplemented to cell culture for 24 hrs before lethal compounds are added to cell culture and further incubated for 24 hrs at 37°C under 5% CO2. On the day of the viability measurement, 10 μL/well of 50% Alamar Blue diluted in media is added and further incubated at 37°C for 6 hrs. Fluorescence intensity (ex/em: 530/590) is measured with a Victor 3 plate reader and the normalized viability is calculated by VL = (IL-I0)/(IV-I0), where VL, I0, IV, and IL are the normalized viability, raw fluorescence intensities from the wells containing media, cells treated with a vehicle (negative control), and cells with the lethal compound (L), respectively. When the effect of a chemical modulator (M) on L is calculated, we instead used the equation: VL|M = (IM, L-I0)/(IM, V-I0), where VL|M, IM, L and IM, V are the normalized viability, and fluorescence intensity from cells treated with M and V, and from cells with M and L. respectively. The viability is typically measured in biological triplicates unless otherwise specified. A representative dose-response curve, the mean and standard error of normalized viability from one replicate are plotted. |
分子量 | 517.66 |
分子式 | C25H31N3O5S2 |
CAS No. | 1083162-61-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 51.8 mg/mL(100 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.9318 mL | 9.6588 mL | 19.3177 mL | 48.2942 mL |
5 mM | 0.3864 mL | 1.9318 mL | 3.8635 mL | 9.6588 mL | |
10 mM | 0.1932 mL | 0.9659 mL | 1.9318 mL | 4.8294 mL | |
20 mM | 0.0966 mL | 0.4829 mL | 0.9659 mL | 2.4147 mL | |
50 mM | 0.0386 mL | 0.1932 mL | 0.3864 mL | 0.9659 mL | |
100 mM | 0.0193 mL | 0.0966 mL | 0.1932 mL | 0.4829 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
FIN56 1083162-61-1 Apoptosis Ferroptosis inhibit GPX4 degradation FIN 56 Inhibitor squalene FIN-56 synthase inhibitor